In healthy people, the body converts the main thyroid hormone T4 into two other forms: T3, which is active, and reverse T3, which is inactive. Although reverse T3 is produced in notable amounts from T4, it breaks down so quickly that it doesn’t add much to the total hormone signal in the blood.
Evidence from Studies
No evidence studies found yet.
What Would Prove This
Per GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this claim, ordered from strongest to weakest.
A systematic review of multiple kinetic tracer studies across diverse populations could confirm whether the relative fluxes of T4 to T3 and rT3 are consistent and whether rT3 turnover rates are universally low in healthy humans.
A systematic review and meta-analysis of all published kinetic tracer studies using [131I]T4 and [125I]T3 in healthy adults (n≥500 total across studies), standardizing methods for plasma sampling, chromatography, and modeling parameters to quantify the proportion of T4 converted to T3 versus rT3, and the half-life of rT3 across populations.
An RCT could test whether manipulating T4 dosing alters rT3 production rates, but this is not feasible for a descriptive kinetic model of normal physiology.
A double-blind, placebo-controlled trial administering graded doses of synthetic T4 (50–200 mcg/day) to 50 healthy adults for 14 days, measuring plasma T3, rT3, and iodide kinetics via serial tracer sampling and modeling, with placebo group receiving no hormone.
A longitudinal cohort could track whether baseline rT3 production rates predict future thyroid dysfunction, but this study does not assess outcomes.
A prospective cohort of 1000 healthy adults aged 25–65, measuring baseline T4-to-rT3 conversion rates via tracer kinetics, then following for 10 years to assess incidence of subclinical or overt thyroid disorders.
A cross-sectional study could correlate rT3 levels with T4 levels in healthy populations, but cannot resolve kinetic pathways.
A cross-sectional study measuring serum T4, T3, and rT3 concentrations via mass spectrometry in 300 healthy adults, stratified by age and sex, to assess whether rT3 levels correlate with T4 levels or metabolic rate.
A case series could describe abnormal T4-to-rT3 conversion in rare disorders, but this study focuses on healthy individuals.
A case series of 10–15 individuals with rare inborn errors of deiodinase enzymes, measuring T4, T3, and rT3 kinetics via tracer studies to compare with healthy controls.